Canada has a $94-billion opportunity to make medicines more affordable
We already know which patents are expiring—the country must move quickly and act on this $94-billion savings opportunity for Canadians.

Over the next decade, hundreds of costly medicines will lose patent protection, opening the door to lower-cost versions. However, barriers could keep them from reaching Canadians for months or even years.
Get Weekend Point of View Newsletter
A round up of the past week’s opinion writers and columnists on Saturdays and Sundays.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy







